Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
Abstract The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivale...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6d2ce266cff0455eb80fcc32049d700d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6d2ce266cff0455eb80fcc32049d700d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6d2ce266cff0455eb80fcc32049d700d2021-12-02T14:26:46ZImmunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles10.1038/s41541-021-00285-92059-0105https://doaj.org/article/6d2ce266cff0455eb80fcc32049d700d2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00285-9https://doaj.org/toc/2059-0105Abstract The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivalent antigen presentation on nanoparticles is an established strategy to increase vaccine-driven immune responses. However, due to nanoparticle instability in vivo, the display of non-native Env structures, and the inaccessibility of many neutralizing antibody (NAb) epitopes, the effects of nanoparticle display are generally modest for Env trimers. Here, we generate two-component self-assembling protein nanoparticles presenting twenty SOSIP trimers of the clade C Tier-2 genotype 16055. We show in a rabbit immunization study that these nanoparticles induce 60-fold higher autologous Tier-2 NAb titers than the corresponding SOSIP trimers. Epitope mapping studies reveal that the presentation of 16055 SOSIP trimers on these nanoparticle focuses antibody responses to an immunodominant apical epitope. Thus, these nanoparticles are a promising platform to improve the immunogenicity of Env trimers with apex-proximate NAb epitopes.Philip J. M. BrouwerAleksandar AntanasijevicMarlon de GastJoel D. AllenTom P. L. BijlAnila YasmeenRashmi RavichandranJudith A. BurgerGabriel OzorowskiJonathan L. TorresCelia LaBrancheDavid C. MontefioriRajesh P. RingeMarit J. van GilsJohn P. MoorePer Johan KlasseMax CrispinNeil P. KingAndrew B. WardRogier W. SandersNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-14 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Philip J. M. Brouwer Aleksandar Antanasijevic Marlon de Gast Joel D. Allen Tom P. L. Bijl Anila Yasmeen Rashmi Ravichandran Judith A. Burger Gabriel Ozorowski Jonathan L. Torres Celia LaBranche David C. Montefiori Rajesh P. Ringe Marit J. van Gils John P. Moore Per Johan Klasse Max Crispin Neil P. King Andrew B. Ward Rogier W. Sanders Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles |
description |
Abstract The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivalent antigen presentation on nanoparticles is an established strategy to increase vaccine-driven immune responses. However, due to nanoparticle instability in vivo, the display of non-native Env structures, and the inaccessibility of many neutralizing antibody (NAb) epitopes, the effects of nanoparticle display are generally modest for Env trimers. Here, we generate two-component self-assembling protein nanoparticles presenting twenty SOSIP trimers of the clade C Tier-2 genotype 16055. We show in a rabbit immunization study that these nanoparticles induce 60-fold higher autologous Tier-2 NAb titers than the corresponding SOSIP trimers. Epitope mapping studies reveal that the presentation of 16055 SOSIP trimers on these nanoparticle focuses antibody responses to an immunodominant apical epitope. Thus, these nanoparticles are a promising platform to improve the immunogenicity of Env trimers with apex-proximate NAb epitopes. |
format |
article |
author |
Philip J. M. Brouwer Aleksandar Antanasijevic Marlon de Gast Joel D. Allen Tom P. L. Bijl Anila Yasmeen Rashmi Ravichandran Judith A. Burger Gabriel Ozorowski Jonathan L. Torres Celia LaBranche David C. Montefiori Rajesh P. Ringe Marit J. van Gils John P. Moore Per Johan Klasse Max Crispin Neil P. King Andrew B. Ward Rogier W. Sanders |
author_facet |
Philip J. M. Brouwer Aleksandar Antanasijevic Marlon de Gast Joel D. Allen Tom P. L. Bijl Anila Yasmeen Rashmi Ravichandran Judith A. Burger Gabriel Ozorowski Jonathan L. Torres Celia LaBranche David C. Montefiori Rajesh P. Ringe Marit J. van Gils John P. Moore Per Johan Klasse Max Crispin Neil P. King Andrew B. Ward Rogier W. Sanders |
author_sort |
Philip J. M. Brouwer |
title |
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles |
title_short |
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles |
title_full |
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles |
title_fullStr |
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles |
title_full_unstemmed |
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles |
title_sort |
immunofocusing and enhancing autologous tier-2 hiv-1 neutralization by displaying env trimers on two-component protein nanoparticles |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/6d2ce266cff0455eb80fcc32049d700d |
work_keys_str_mv |
AT philipjmbrouwer immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT aleksandarantanasijevic immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT marlondegast immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT joeldallen immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT tomplbijl immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT anilayasmeen immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT rashmiravichandran immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT judithaburger immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT gabrielozorowski immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT jonathanltorres immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT celialabranche immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT davidcmontefiori immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT rajeshpringe immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT maritjvangils immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT johnpmoore immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT perjohanklasse immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT maxcrispin immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT neilpking immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT andrewbward immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles AT rogierwsanders immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles |
_version_ |
1718391315987693568 |